Historique
Bulletin de Périodique
Drug Testing and Analysis , Vol.7, n°1-2 - January-February 2015
Paru le :
01/01/2015
Année
2015
Page(s) :
1-172
Langue(s) :
Anglais
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Note de contenu :
SELECTION :
- Annual banned-substance review: analytical approaches in human sports drug testing. Thevis M., Kuuranne T., Geyer H., Schänzer W., p. 1-20.
- Copper thiocyanato complexes and cocaine - a case of 'black cocaine'. Laussmann T., Grzesiak I., Krest A., Stirnat K., Meier-Giebing S., Ruschewitz U., et al., p. 56-64.
- Detection of iso-alpha-acids to confirm beer consumption in postmortem specimens. Rodda L.N., Gerostamoulos D., Drummer O.H., p. 65-74.
- A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements. Cohen P.A., Travis J.C., Venhuis B.J., p. 83-87.
- Targeting misuse of 2-amino-N-ethyl-1-phenylbutane in urine samples: in vitro–in vivo correlation of metabolic profiles and development of LC-TOF-MS method. Kobayashi M., Pelander A., Ketola R.A., Leinonen A., Kuuranne T., p. 89-94.
- Impact of oral fluid collection device on cannabinoid stability following smoked cannabis. Anizan S., Bergamaschi M.M., Barnes A.J., Milman G., Desrosiers N., Lee D., et al., p. 114-120.
- Qualitative analysis of seized synthetic cannabinoids and synthetic cathinones by gas chromatography triple quadrupole tandem mass spectrometry. Gwak S., Arroyo-Mora L.E., Almirall J.R., p. 121-130.
- Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue. Sobolevsky T., Prasolov I., Rodchenkov G., p. 131-142.
- Annual banned-substance review: analytical approaches in human sports drug testing. Thevis M., Kuuranne T., Geyer H., Schänzer W., p. 1-20.
- Copper thiocyanato complexes and cocaine - a case of 'black cocaine'. Laussmann T., Grzesiak I., Krest A., Stirnat K., Meier-Giebing S., Ruschewitz U., et al., p. 56-64.
- Detection of iso-alpha-acids to confirm beer consumption in postmortem specimens. Rodda L.N., Gerostamoulos D., Drummer O.H., p. 65-74.
- A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements. Cohen P.A., Travis J.C., Venhuis B.J., p. 83-87.
- Targeting misuse of 2-amino-N-ethyl-1-phenylbutane in urine samples: in vitro–in vivo correlation of metabolic profiles and development of LC-TOF-MS method. Kobayashi M., Pelander A., Ketola R.A., Leinonen A., Kuuranne T., p. 89-94.
- Impact of oral fluid collection device on cannabinoid stability following smoked cannabis. Anizan S., Bergamaschi M.M., Barnes A.J., Milman G., Desrosiers N., Lee D., et al., p. 114-120.
- Qualitative analysis of seized synthetic cannabinoids and synthetic cathinones by gas chromatography triple quadrupole tandem mass spectrometry. Gwak S., Arroyo-Mora L.E., Almirall J.R., p. 121-130.
- Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue. Sobolevsky T., Prasolov I., Rodchenkov G., p. 131-142.
Cote :
Abonnement